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A pairwise comparison of the nucleic acid sequence of 
168 bases from 152 wild-type or unique cell culture- 
adapted strains of hepatitis A virus (HAV) revealed 
that HAV strains can be differentiated genetically into 
seven unique genotypes (I to VII). In general, the 
nucleotide sequence of viruses in different genotypes 
differs at 15 to 25 % of positions within this segment of 
the genome. Viruses from four of the genotypes (I, II, 
III and VII) were recovered from cases of hepatitis A in 
humans, whereas viruses from the other three geno- 
types (IV, V and VI) were isolated only from simian 
species developing a hepatitis A-like illness during 
captivity. Among non-epidemiologically related 
human HAV strains, 81 were characterized as geno- 
type I, and 19 as genotype III. Within each of these 
major genotypes, there were two distinct groups (sub- 
genotypes), which differed in sequence at approxi- 
mately 7-5 % of base positions. Each genotype and sub- 
genotype has a characteristic amino acid sequence in 
this region of the polyprotein, with the most divergent 
genotypes differing at 10 of 56 residues. Strains 
recovered from some geographical regions belonged to 
a common (endemic) genotype, whereas trains from 
other regions belonged to several, probably imported, 
genotypes. Thus, HAV strains recovered in North 
America were for the most part closely related at the 
nucleotide sequence level, whereas in other regions, 
such as Japan and Western Europe, HAV strains were 
derived from multiple genotypes or sub-genotypes. 
These data indicate that patterns of endemic transmis- 
sion can be differentiated from situations in which 
infections are imported ue to travel. 
Introduction 
Human hepatitis A virus (HAV), a hepatotropic member 
of the picornavirus family (Melnick 1982; Gust et al., 
1983), has recently been reclassified as the type species of 
a new genus, Hepatovirus (Minor, 1991). HAV was 
previously classified as enterovirus 72 based upon its 
physical properties, which are similar to those of other 
enteroviruses, and its faecal-oral route of transmission. 
Despite its overall physical and epidemiological simi- 
larity to enteroviruses, the unique structural composition 
of HAV, its stability characteristics, tissue tropism and 
genetic distance from members of other picornavirus 
genera indicate that HAV is unique within the picorna- 
virus family, and have provided the impetus for the 
establishment of a separate genus for HAVs (Palmen- 
berg, 1989). As in other picornaviruses, the large open 
reading frame present in the genome of HAV may be 
divided into three functional regions, termed P1, P2 and 
P3 (Rueckert & Wimmer, 1984). The P1 genomic region 
encodes the capsid polypeptides (VP1, VP2, VP3 and a 
putative VP4), and the P2 and P3 regions encode the 
non-structural polypeptides necessary for virus repli- 
cation. The genome itself is 7.5 kb in length and of 
positive sense. 
Antibodies to human HAV elicited by either natural or 
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experimental infection do not distinguish between 
individual strains of HAV, and thus there is only a single 
serotype of human HAV (Gellis et al., 1945; Neefe et al., 
1946; Provost et al., 1973; Rakela et al., 1976; Lemon & 
Binn, 1983). Furthermore, monoclonal antibodies raised 
to various strains of human HAV have failed to 
differentiate more than one antigenic type (MacGregor 
et al., 1983; Dawson et al., 1984; Crevat et al., 1990). 
Owing to this high degree of antigenic conservation 
among human HAV strains, infection with HAV is likely 
to confer life-long immunity that protects against 
subsequent symptomatic reinfection. As expected, the 
lack of antigenic diversity is mirrored by a high degree of 
conservation in the amino acid sequences of capsid 
proteins (Ticehurst et al., 1989). 
Early comparative studies of the nucleotide sequences 
of different human HAV strains suggested that isolates 
of diverse epidemiological origin were remarkably 
closely related (Ticehurst et al., 1989). However, more 
recent nucleotide sequencing of selected genome regions 
encoding the C terminus of VP3, the N terminus of VP1, 
or the putative VP1/2A junction region of wild-type 
HAV strains present in human specimens has demon- 
strated substantial sequence heterogeneity. These studies 
have suggested that sequence relatedness can be corre- 
lated with the geographical origin of viruses (Jansen et 
al., 1990; Robertson et al., 1991 a). In this manuscript we 
present a comprehensive analysis of sequence data 
derived from the VP1/2A junction region, resulting in 
the definition of seven distinct genotypes of HAV. The 
107 unique virus strains included in this analysis 
represent the majority of HAV strains available world- 
wide. This analysis, which includes virus strains of both 
human and simian origin, provides a framework for the 
future use of partial genomic sequencing in defining the 
molecular epidemiology of HAV infection, and in the 
design of improved strategies for control of hepatitis A. 
Methods 
Virus strains. One-hundred and seventy-one i dividual virus isolates 
or clinical specimens containing HAV (stools, liver suspensions and 
serum) were assembled from a variety of sources, including the HAV 
Strain Bank organized by the Programme for Vaccine Development of 
the WHO. For each virus, the genomic sequence in the region of the 
VP1/2A cleavage site was determined, as described below. However, 
only wild-type viruses from primary clinical material, or cell culture 
isolates of HAV which had unique nucleotide s quences were included 
in the analysis of the genetic relatedness among HAV strains (total 152 
strains), as preliminary studies have indicated that some cell cu ture 
isolates are in fact laboratory virus contaminants (Jansen et al., 1990). 
Virus strains included in the analysis of genetic relatedness are listed in 
Table 1 according to their presumed geographical source and date of 
recovery (only a single virus is listed where multiple identical viruses 
were recovered from patients involved in a common outbreak of 
disease). The 19 cell culture isolates found to have VP1/2A sequences 
identical to those of common laboratory strains of HAV are listed in 
Table 2. 
Antigen capture, reverse transcription and polymerase chain reaction 
(PCR). Virus in stool or liver suspensions (2 to 20~), or from cell culture 
was affinity-captured using anti-HAV-specific antibodies, followed by 
heat denaturation f the viral capsid and RNA, reverse transcription 
with an appropriate negative-sense primer and subsequent amplifi- 
cation of cDNA by PCR as described previously (Jansen et al., 1990; 
Robertson et al., 199la). Viral RNA was recovered from serum by 
proteinase K digestion and phenol-chloroform extraction, followed by 
ethanol precipitation prior to reverse transcription a d PCR amplifi- 
cation (Robertson et al., 1991a). The genome region selected for 
comparison was located at the putative junction between the C
terminus of VP1 and the N terminus of P2A (Cohen et al., 1987). This 
region has been shown previously to have a relatively high degree of 
sequence variability in comparison with other regions of the HAV 
genome (Brown et al., 1989). It is also analogous tothe region utilized 
for a similar comparative study of nucleotide s quences of poliovirus 
strains (Rico-Hesse etal., 1987). However, it is important to note that 
the precise HAV VPI/2A cleavage site has yet to be determined. The 
oligonucleotide primer pairs used for PCR of HAV cDNA included: 
+ 2984 and - 3285, + 2984 and - 3265, + 2949 and - 3285, + 2934 
and - 3285, + 2799 and - 3273 (Table 3). 
DNA purification and nucleic acid sequencing. Amplified cDNA was 
purified by agarose or acrylamide gel electrophoresis and sequenced 
either by extension ofa 32p-5-end-labelled primer (Jansen et al., 1990), 
or by incorporative [35S]- (Robertson etal., 1991 a) or [32p]dideoxy- 
nudeotide s quencing in the presence of10% DMSO (Winship, 1989) 
with Sequenase (United States Biochemicals). 
Computer analysis of sequences. Nucleotide sequences were analysed 
using computer algorithms designed for the VAX computer and 
provided by the University of Wisconsin (Devereux et al., 1984). 
Dendrogram analyses were carried out using a program written by 
Mark Pallansch (CDC) and used previously for the analysis of 
poliovirus genomic segments (Rico-Hesse etal., 1987). 
Results 
Genetic analysis o f  wild-type HA V strains 
We compared the partial nucleotide sequences of 152 
individual HAVs recovered from stool, liver, serum or 
cell culture materials. Most of these strains were studied 
directly in human clinical materials, although we also 
included cell culture isolates of HAV when their 
sequences were unique compared to common laboratory 
strains of HAV (HM175, MBB or HAS15) (see 
Methods). Together, these strains originated in 29 
countries in seven continents and subcontinents and thus 
include HAV strains causing hepatitis in all regions of 
the world. The earliest strains to be recovered were 
CR326 and MS-l, which were identified in human faecal 
specimens collected approximately 30 years ago (Table 
1). However, most of the strains we studied were 
collected between 1978 and 1990. Four of the HAV 
strains were recovered from non-human primates held in 
captivity: PA21 from owl monkeys, JM55 and Cy145 
from cynomolgus monkeys, and AGM27 from African 
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Tab le  1. Genotype, source and year of recovery of HA V strains* 
Strain Genotype Location Year Contributor 
North America 
MS-1 IA Willowbrook, N.Y. 1964 S.M. Krugman 
SD-11 1A San Diego, Ca. 1974 R.H.  Purcell 
LA IA Los Angeles, Ca. 1975 J. Rakela t 
AK76 IA Alaska, U.S.A. 1976 Arctic Investigation Laboratory 
FR-AL IA Fort Richardson, Alaska 1976 W. Bancroft 
GA76 IIIA Georgia, U.S.A. 1976 CDC Archive sample 
HASI5 IA Phoenix, Ariz. 1979 CDC Archive sample 
LV-BE IA Levenworth, Kan. 1982 R. Redfield 
CA85 IA Berkley, Ca. 1985 L.S. Oshiro 
HA88 IA Honolulu, Haw. 1988 M.E. Melish 
UT88 IA Utah, U.S.A. 1988 A. Pavia 
GAS8 IA Atlanta, Ga. 1988 C.H. Cowart 
NC-1 IA Chapel Hill, N.C. 1989 E. Brown 
CA89 IA Los Angeles, Ca. 1989 J. Vargas 
GA90 IA Georgia, U.S.A. 1990 M. Niu 
MT90 IA Montana, U.S.A. 1990 L. Polish 
Central and South America 
CR326 IA Costa Rica 1960 V. Villarejos:~ 
RDJ IA Brasilia, Brazil 1980 J.V. Parry 
Ep-13-006 IA Belem, Brazil 1981 G. Bensabath 
H-201 IB S. America (Sweden) 1982 A. Widell 
Ep-35-730 IA Maraba, Brazil 1985 G. Bensabath 
MEX-1 IA Mexico (U.S.A.) 1986 S. Lemon 
Ep-49.674 IA Belem, Brazil 1988 G. Bensabath 
Arg90 IA Argentina 1990 J. Pintera 
Europe 
H-122 I l iA Malmo, Sweden 1979 A. Widell 
H-132 Il iA Malmo, Sweden 1979 A. Widell 
H-141 I l i a  Malmo, Sweden 1979 A. Widen 
KPH IIIB Copenhagen, Denmark 1979 A. Wideli 
KMW*I§ IA Switzerland 1979 G. Siegl 
CP IA England 1979 J .V. Parry 
CF-53 II Clermont-Ferrand, France 1979 M. Deloince 
H-148 IA Vasteras, Sweden 1980 A. Widell 
H-152 IB Germany (Sweden) 1981 A. Widell 
H-174 Il iA Lund, Sweden 1978 A. Widell 
GR7 IA Grafenwohr, Germany 1982 S. Lemon 
RM 238 IA Czechoslovakia 1982 R. Scheid 
JF 136 IA Czechoslovakia 1982 R. Scheid 
Agl 1 IB Athens, Greece 1983 G. Papaevangelou 
Ag5978 IB Thiva, Greece 1983 G. Papaevangelou 
Ag6084 IB Athens, Greece 1983 G. Papaevangelou 
Ag6014 IB Chalkis, Greece 1983 G. Papaevangeiou 
H-209 IIIA Malmo, Sweden 1984 A. Widell 
H-213 Il iA Malmo, Sweden 1984 A. Widell 
H-217 I l i a  Malmo, Sweden 1984 A. Widell 
H-228 Il iA Malmo, Sweden 1986 A. Widell 
Carina IA Italy 1986 A. Pana 
U.S.S.R. 
1406 IA East Siberia, U.S.S.R. 1983 M. Balayan 
2424 IA Lithuania 1985 M. Balayan 
406-1 IA Gorky, U.S.S.R. 1987 M. Balayan 
Chilli 
China 81 IA Shanghai, P.R.C. 1981 Z.Y. Xu 
China 83 IA Jiansu, P.R.C. 1983 Z.Y. Xu 
LCDC-I§ IA Shanghai, P.R.C. 1984 R. Chaudhury 
$85-1§ IA Sichuan, P.R.C. 1985 Anti epidemic station 
PRC16 IA Shanghai, P.R.C. 1988 M. Hu 
PRC37 IA Shanghai, P.R.C. 1988 M. Hu 
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Tab le  1.--(continued) 
Strain Genotype Location Year Contributor 
Southeast Asia, Japan and India 
KRM031 IA Saga, Japan 1977 
KRM016 IIIB Saga, Japan 1977 
KRM003 IIIB Fukuoka, Japan 1979 
H-229 IIIA Sri Lanka (Sweden) 1984 
SMA 292 IIIA Senang, Malaysia 1986 
M-136 IA Mie, Japan 1986 
M-138 IA Mie, Japan 1986 
SR082 IA Bangkok, Thailand 1987 
SR035 IA Bangkok, Thailand 1987 
SR102 IA Bangkok, Thailand 1987 
PMA 32 IA Penang, Malaysia 1988 
TK023 IIIA Kathmandu, Nepal 1989 
India90 IIIA India 1990 
PH074 IA Nan, Thailand 1990 
A-4 IA Aichi, Japan 1990 
A-12 IA Aichi, Japan 1990 
A-113 IA Aichi, Japan 1990 
A-127 IA Aichi, Japan 1990 
A-129 IA Aichi, Japan 1990 
A-148 1A Aichi, Japan 1990 
A-149 IA Aichi, Japan 1990 
A-162 IIIB Aichi, Japan 1990 
A-167 IA Aichi, Japan 1990 
A-177 IIIB Aichi, Japan 1990 
A-185 1A Aichi, Japan 1990 
A-261 IA Aichi, Japan 1990 
TJ-D-1 IA Gifu, Japan 1990 
S-3 IA Shizuoka, Japan 1990 
S-6 IA Shizuoka, Japan 1990 
S-13 IA Shizuoka, Japan 1990 
M-25 IIIB Mie, Japan 1990 
M-30 IA Mie, Japan 1990 
M-53 IA Mie, Japan 1990 
M-63 IA Mie, Japan 1990 
M-74 IA Mie, Japan 1990 
M-91 IA Mie, Japan 1990 
M-100 IA Mie, Japan 1990 
M-102 IA Mie, Japan 1990 
M-116 IA Mie, Japan 1990 
M-118 IA Mie, Japan 1990 
KS-T-1 IA Tokyo, Japan 1990 
Y. Moritsugu 
Y. Moritsugu 
Y. Moritsugu 
A. Widell 
I. Gust 
T. Ishizu 
T. Ishizu 
B. Innis 
B. Innis 
B. Innis 
I. Gust 
B. Innis 
B. Khanna 
B. Innis 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
S. Isomura 
Y. Moritsugu 
K. Ito 
K. Ito 
K. Ito 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
T. Ishizu 
Y. Moritsugu 
Australia, Africa and the Middle East 
HM175 IB Australia 1976 I. Gust 
MBB IB N. Africa (Germany) 1978 G. Frosner 
TKM005 IB Iraq (Japan) 1981 Y. Moritsugu 
TKM002 IA Nigeria (Japan) 1981 Y. Moritsugu 
H153 IB Tunisia (Sweden) t981 A. Widell 
No. 4 IB N. Africa ? H. Garelick 
Jor88 IB Amman, Jordan 1988 A. Toukan 
SLF88 VII Sierra Leone 1988 L. Chapman 
Non-human primates 
PA21 Il iA Panama 1980 Aotus trivirgatus 
JM55 VI Indonesia (U.S.S.R.) 1985 Macacafascicularis 
AGM27 V Kenya (U.S.S.R.) 1985 Cercopithecus aethiops 
Cy145 IV Philippines (U.S.A.) 1988 Macacafascicularis 
* When the source of infection was strongly considered to be travel-associated, the strain was 
classified by the country in which the infection was presumed to have been acquired (the country within 
which the strain was actually recovered is indicated in parentheses). Some dates may represent year of 
publication rather than actual year of recovery. When strains were recovered from patients in a 
common outbreak, only one strain is listed (see Table 4). 
t Najarian et al. (1985). ~ Linemeyer t al. (1985). § Probably a contaminant. 
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Table 2. Cell culture isolates ofHA V excluded from 
analysis 
Isolate Location Year Passage Cells 
MBB-like isolates 
CLF Switzerland 1983 1 MRC-5 
GBM Germany 1976 1 MRC-5 
LSH/S England 1983 1 MRC-5 
KMW-1 * Switzerland 1979 7 MRC-5 
Sy77 China 1978 5 MRC-5 
BR 5l/7 Germany 1982 1 PRC/PRF/5 
CF979 U.S.A. 1979 1 PRC/PRF/5 
SM1 China 1978 6 PRC/PRF/5 
190/1 Greece 1987 2 FRhK4 
HEL2 Germany 1986 3 ? 
HM175-1ike isolates 
MD1 U.S.A. 1981 ? AGMK? 
$84-1 China 1984 15 Primary human lu g 
$85-1" China 1985 3 Primary human lu g 
HLJA China ? 5 Primary human lung 
$7 China ? 2 ? 
HAS15-1ike isolates 
LCDC-I* China 1984 20 FRhK4 
* Those isolates strongly suspected of being contaminants. 
Table 3. Primers used for amplification and sequencing 
Positive sense primers 
+ 2799:5' ATTCAGATTAGACTGCCTTGGTA Y 
+ 2891:5' GGTTTCTATTCAGATTGCAAATTA 3' 
+ 2933:5' TTTGTCTTTTAGTTGTTATTTGTCTGT 3' 
+ 2934:5' TTGTCTTTTAGTTGTTATTTGTCTG 3' 
+ 2949:5" TATTTGTCTGTCACAGAACAATCAG Y 
Negative sense primers 
- 3192:5' AGGAGGTGGAAGCACTTCATTTGA 3' 
- 3265:5' CATTATTTCATGCTCCTCAG 3" 
- 3273:5' CCAAGAAACCTTCATTATTTCATG 3' 
- 3285:5' AGTCACACCTCTCCAGGAAAACTT 3' 
- 3375"5" AGTAAAAACTCCAGCATCCATTTC Y 
green monkeys. The remainder of the strains were from 
human cases of hepatitis A. A detailed list of the strains 
is shown in Table 1. 
The extent of nucleotide variation among these 152 
strains within a 168 base region encoding the putative 
VPI/2A junction provided a measure of the relatedness 
of individual human strains to each other, and to recently 
characterized simian HAV strains (Nainan et al., 1991 ; 
Tsarev et al., 1991). A pairwise analysis of the nucleotide 
sequences of cDNA amplified by a PCR-based pro- 
cedure resulted in the dendrogram shown in Fig. 1. This 
figure includes only 93 of the 152 strains we evaluated, as 
a number of strains with sequences identical to those of 
others (Table 4) were excluded to simplify the graphic 
comparison. These data confirm the relatively high 
degree of genomic conservation found among HAV 
strains in general, but they also demonstrate the 
existence of genetically related groups which are often 
(but not always) associated with certain geographical 
regions. 
Based upon percentage nucleotide identity, we have 
grouped strains of HAV into seven major genotypes (Fig. 
1 and Table 1). Adopting criteria applied to the 
comparison of poliovirus equences (Rico-Hesse t aL, 
1987), we have defined an HAV genotype as a group of 
viruses having nucleotide sequences which differ from 
each other at no more than 15 % of base positions (Jansen 
et al., 1991). Four of the genotypes shown in Fig. 1 (I, II, 
III and VII; original genotype numbering from Jansen et 
al., 1990) include strains of HAV that have been 
associated with human disease, whereas the remaining 
three genotypes (IV, V and VI) each include a single 
unique simian HAV strain. Genotype III is unique in 
that it includes strains that have been recovered from 
both human and non-human primate sources. 
Genotype I 
This genotype includes 82 of the 104 (80%) human HAV 
strains studied (Table 1 and Fig. 1). We further divided 
this genotype into two sub-genotypes (IA and IB) 
differing from each other at approximately 7-5 % of base 
positions (Jansen et al., 1991), as the dendrogram (Fig. 1) 
and related amino acid sequences (Fig. 2) suggest a 
natural division. Sub-genotype IA comprises the 
majority of the human strains studied (69 of 104, 67%), 
and includes trains found world-wide. It constitutes the 
major virus population in both North and South 
America, China, Japan, the former U.S.S.R. and 
Thailand. However, three geographically related clusters 
of viruses with closely related sequences are found in this 
genotype. These include one group of strains from the 
U.S.A., another from Japan and a third group recovered 
both in Japan and China (Fig. 1, shaded areas). The 
remaining strains within the IA sub-genotype appear to 
be more randomly dispersed with respect to geographical 
origin. Sub-genotype IB contains strains from Jordan, 
North Africa, Australia, Europe, Japan and South 
America. However, the majority of these strains were 
recovered from locations near the Mediterranean (Table 
1). 
Genotype III 
Most of the remaining human HAV strains segregate 
into a single genotype that can also be divided into two 
sub-genotypes, II IA and IIIB. The prototype virus strain 
of the IIIA sub-genotype, PA21, was originally isolated 
from recently captured Panamanian owl monkeys 
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Year ~ Name 
~O~dl~ NM°" ~ 
81 F~u ly  H-152HM'175 
81 el /u~sla TKM005 H°153 
88 do~n Jot88 
Greoc8 A~O~4 
82 ~outm~medca Ag11 H-201 
90 Jsl~m M-118 
90 Japan A-167 
90 Japen A-185 
90 Japan S-6 
90 J.apan A-12 
90 J.apan M-116 
90 japan A-127 
90 Japan M-53 
90 Japan A-261 
90 ~l~n A-148 
64 MS-1 
90 Japan A-148 
90 Japan M-91 
87 USSR 406-I 
83 USSR 1406 
82 Cz~lovek ia  RM238 
87 Tlvdlsnd SRI02 
81 Nlgeda TKMO02 
90 Thailand PH-074 
85 USSR 2424 
87 TIl~land SR082 
86 Malayrga PMA32 
87 ThaJlsnd SR035 
86 Japan M-136 
86 Ja~m M-138 
77 J~oen KRM031 
76 USA FR-AL 
76 USA AK76 
86 MeJdco Mex-1 
75 USA LA 
80 Sweden H-148 
79 USA HAS-15 
74 USA SD- 11 
85 USA CA85 
88 USA GAS8 
88 USA UT88 
88 USA HA88 
90 USA GAg0 
82 USA LV-BE 
82 FR Germany GR-1 
89 USA CA89 
79 Swllzodand " KMW-1 
89 USA NC-I 
81 Brazil Ep-13.006 
80 Brazil RDJ 
76 Er@and CP 
60 Costa Rica CR326 
86 Italy Cadna 
90 Arg@~lna Argg0 
88 Braze Ep-49.674 
85 BmzH F_p-35.730 
82 Czechoslovalda JF-136 
88 PRC PRC37 
81 PRC CNna81 
85 PRC * $85-I 
90 Japan A-129 
84 PRC LCDC-I 
83 PRC Chlna83 
.o  
79 CF-53 
88 Slenl Leone SLF88 
84 Sd l_anka H-229 
76 USA GA76 
86 ,~nna SMA292 
78 H-174 
84 H -209 
80 PA21 
90 India In,lag0 
89 ~Nu~ TKO23/Sg 
85 Indonesia JM55 
I 
Fig. 1. Genetic relatedness between 93 individual HAV strains. 
The dendrogram illustrates a pairwise comparison of sequences 
within a 168 base segment at the VP I/2A junction (nucleotides 
3024 to 3191). Nucleotides are numbered according to the wild- 
type HM175 HAV sequence (Cohen et al., 1987). The location 
of the node between strains or groups of strains indicates the 
approximate percentage nucleotide identity between sequences 
shown on the abscissa. Roman numerals I to VII designate the 
respective genotype groupings ( >t 85 % identity), whereas A and 
B designate sub-genotypes (/> 92-5% identity). Only selected 
strains having identical sequences are shown (see Table 4). 
I ! 
1 A 
II 
) 
VII 
IV 
I 
lOO 
l 
95  
V 
I I VI 
9O 85 
Nucleotide identity (%) 
I I 
80  75 
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VPI  P -2A 
> - -  > 
ESMMSRIAAGDLESSVDDPRSEEDRRFE280 290 300 SHIECRKPYKELRLEVGKQRLKYAQEEL I0  20  
IA  Consensus  . . . . . . . . . . . . . . . . . . . . . . . . .  
,p~,.73o ......................... [:2 2[:[::::[22:[~i~[[::22:[:22 
' 1 ' i~q0 0 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  y . . . . . . . . . . . . . . . . . . . . . . .  
PRC16 (7)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  D . . . . . . . . . . . . . . . . .  
$23- I  (3)  . . . .  N . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . .  
IB  Consensus  . . . . . . . . . . . . . . . . . . . . . . . .  K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
No4 . . . . . . . . . . . . . . . . . . . . . . . .  K . . . . . . . . . . . . . . . . . . . . . . . . .  R . . . . .  
I I  0F -53  .T  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S . . . . . . . . . . . . . . . . . . . . . . .  
I I IA  Consensus  .T . .D . . . L  . . . . . . . . . . . . . . . .  K . . . . . .  K . . . . . . . . . . . . . . . . . . . . . . .  
PA21 TV.D. . . L  . . . . . . . . . . .  T . . . .  K . . . . . .  KW . . . . . . . . .  
I I IB  consensus  .T .LD. . . L  . . . . . . . . . . . . . . . .  K . . . . . .  K . . . . . . . . . . . . . . . . . . . . . . .  
KPH .T . .D . . . L  . . . . . . . . . . . . . . . .  K . . . . . .  K . . . . . . . . . .  
IV  Cy145 .N .LD, . .G  . . . . . . . . . . .  TD . . . . . . . . . .  *K  . . . . . . . . . . . . . .  F . . .R .  ,. 
V I tGM27 . . . LD. . .S  . . . . . . . . . . . .  A°  .K  . . . . . . .  QG . . . . . . .  M . . . . . . . . . .  M . . .  
V I  JM55 .T .LD. . .S  . . . . . . . . . . . .  A , .K  . . . . . . .  QG . . . . . . .  M . . . . .  T . . . . . . . .  
Fig. 2. Comparison ofthe predicted amino acid sequences near the 
putative VP 1/2A junction. The consensus amino acid sequence for the 
predominant sub-genotype IA is shown on the top line, with the 
corresponding amino acid residue numbers for VP1 and P2A based on 
the cleavage site proposed for HAV strain HM 175 (Cohen et al., 1987). 
The consensus for each genotype is shown, along with the s quence of 
strains which differ from the consensus (numbers in parentheses 
indicate the number of strains with an identical divergent s quence). 
Dots indicate conserved amino acids; differences are shown by the 
appropriate single letter amino acid code. An asterisk indicates a 
deletion. 
(Brown et al., 1989). However, closely related viruses 
have subsequently been identified in specimens collected 
from humans with hepatitis A in India, Sri Lanka, 
Nepal, Malaysia, Sweden and the U.S.A. (Jansen et al., 
1991 ; Khanna et al., 1991 ; Robertson et al., 1991 b). The 
IIIB sub-genotype is responsible for cases of HAV 
infection in Japan and Denmark. 
Genotypes H and VII 
These two genotypes each contain only a single strain. 
Genotype II is represented by a strain isolated in France 
in 1979, CF-53, whereas genotype VII contains a strain 
isolated in Sierra Leone in 1988, SLF88. These strains 
differ from each other at approximately 17~ of base 
positions, and from other HAV strains by 20 to 25 %. The 
CF-53 strain was recovered from a patient with typical 
disease in an otherwise unremarkable outbreak of 
hepatitis A in central France. The SLF88 strain was 
recovered from the liver of a patient who died with 
fulminant hepatitis A. 
Genotypes IV, V and V! 
The remaining three genotypes are each represented by a 
single unique virus strain recovered from an Old World 
monkey species. Two of these viruses were recovered at a 
single primate holding facility in the Soviet Union, one 
from a cynomolgus macaque (Macaca fasicularis) re- 
cently imported from Indonesia (genotype VI, JM55 
virus), and the other from an African green monkey 
(Cercopithecus aethiops) imported from Kenya (genotype 
V, AGM27 virus). The third of these simian strains 
(genotype IV, Cy145 virus) was recovered in Atlanta, 
Ga., U.S.A. from a cynomolgus macaque imported from 
the Philippines. These three simian strains tend to differ 
genetically as much between themselves as they do from 
the human viruses. The AGM27 and JM55 strains 
appear to be more closely related to each other than to the 
Cy145 strain, even though they were recovered from 
different primate species. 
Amino acid sequence diversity 
The nucleotide sequence heterogeneity in this region of 
the HAV genome of these 108 virus strains results in only 
limited differences in the amino acid sequence (Fig. 2). 
Within sub-genotype IA, the amino acid sequence is 
conserved with the exception of a cluster of strains from 
China and Japan that have an Asn substitution at Met 
277 of VP1 (residue 1-277) and a Gly substitution at Arg 
2A-6, or an Asp substitution at Glu 2A-10. The amino 
acid sequences of sub-genotype IB strains are also highly 
conserved, and differ from most sub-genotype IA strains 
in that they have a Lys substitution at Arg 1-297. 
Although the nucleotide sequences of the CF-53 and 
SLF88 viruses (genotypes II and VII) differ from each 
other and those of genotype I and III viruses at about 
15% of base positions, their predicted amino acid 
sequences are identical in this region, and include a Ser 
substitution at Thr 1-274 and a Cys substitution at Ser 
2A-5. Greater differences are evident in the amino acid 
sequences of the remaining four genotypes (Fig. 2). The 
amino acid substitutions that distinguish the genotype 
III viruses from the consensus equence derived from 
genotype I viruses include a Thr residue at Ser 1-274, Asp 
at Ser 1-277, Leu at Ala 1-281, Lys at Arg 1-298 and Lys 
at Cys 2A-5. The common sites of amino acid substi- 
tutions within simian genotypes IV to VI include Leu at 
Met 1-276, Asp at Ser 1-277, Ser or Gly at Ala 1-281, Ala 
or Asp at Glu 1-294, Glu or a deletion at Cys 2A-5, and 
Gly or Lys at Arg 2A-6. In addition, there are several 
other substitutions in the amino acid sequences of these 
three strains (Fig. 2). Overall, certain residues are more 
likely to be sites of subsitutions in the different genotypes 
than others. These hypervariable r sidues include 1-273, 
1-277, 1-281, 1-294, 2A-5, 2A-6 and 2A-24, at each of 
which at least three different amino acids are found in 
different genotypes. 
Molecular epidemiology of HA V 
The ability to determine the genotype of HAV strains 
during epidemic or endemic periods offers the potential 
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Table 4. HA V strains with identical sequences in the 168 base VP1/2A region 
Strain Genotype Location Year Contributor 
GRI* IA Grafenwohr, Germany t982 S. Lemon 
LV-BE Levenworth, Kan. 1982 R. Redfield 
GA90 IA Georgia, U.S.A. 1990 M. Niu 
MT90 Montana, U.S.A. 1990 L. Polish 
HM175 IB Australia 1976 I. Gust 
H-152 t Germany (Sweden) 1981 A. Widell 
FR-AL IA Fort Richardson, Alaska 1976 W. Bancroft 
AK76* Alaska, U.S.A. 1976 Arctic Investigation Laboratory 
China83 IA Jiansu, PRC 1983 Z.Y. Xu 
LCDC-I Shanghai, PRC 1984 R. Chaudhury 
H-122 Il iA Malmo, Sweden 1979 A. Widell 
H-141 Malmo, Sweden 1979 A. Widell 
H-209 IIIA Malmo, Sweden 1984 A. Widell 
H-213 Malmo, Sweden 1984 A. Widell 
H-228 Malmo, Sweden 1986 A. WideU 
Agl 1 IB Athens, Greece 1983 G. Papaevangelou 
Ag5978 Thiva, Greece 1983 G. Papaevangelou 
Ag6084 IB Athens, Greece 1983 G. Papaevangelou 
Ag6014 Chalkis, Greece 1983 G. Papaevangelou 
KRM016* IIIB Saga, Japan 1977 Y. Moritsugu 
KRM003 Kyushu, Japan 1979 Y. Moritsugu 
A-162, Aichi, Japan 1990 S. Isomura 
A-177 IIIB Aichi, Japan t990 S. Isomura 
A-229t Aichi, Japan 1990 S. Isomura 
A-149" IA Aichi, Japan 1990 S. Isomura 
A-204 Aichi, Japan 1990 S. Isomura 
A-211 Aichi, Japan 1990 S. Isomura 
A-322 Aichi, Japan 1990 S. lsomura 
M-87 Aichi, Japan 1990 S. Isomura 
M-63t Mie, Japan 1990 T. Ishizu 
A-167 IA Aichi, Japan 1990 S. Isomura 
A-181 Aichi, Japan 1990 S. Isomura 
M-118, Mie, Japan 1990 T. Ishizu 
M-119 Mie, Japan 1990 T. Ishizu 
M-121 Mie, Japan 1990 T. Ishizu 
TJ-D-I* Gifu, Japan 1990 Y. Moritsugu 
KS-T-1 Tokyo, Japan 1990 Y. Moritsugu 
M-74 Mie, Japan 1990 T. Ishizu 
M-75 Mie, Japan 1990 T. Ishizu 
S-6 Shizuoka, Japan 1990 K. Ito 
A-127 IA Aichi, Japan 1990 S. Isomura 
M-100~" Mie, Japan 1990 T. Ishizu 
S-322 Shizuoka, Japan 1990 K. Ito 
A-4 IA Aichi, Japan 1990 S. Isomura 
A-8 Aichi, Japan 1990 S. Isomura 
A-37 Aichi, Japan 1990 S. Isomura 
A-192 Aichi, Japan 1990 S. Isomura 
A-226 Aichi, Japan 1990 S. Isomura 
A-231 Aichi, Japan 1990 S. Isomura 
A-302 Aichi, Japan 1990 S. Isomura 
A-43t Aichi, Japan 1990 S. Isomura 
A-174 t Aichi, Japan 1990 S. Isomura 
M-30 t Mie, Japan 1990 T. Ishizu 
M-495" Mie, Japan 1990 T. Ishizu 
M-54 t Mie, Japan 1990 T. Ishizu 
M-61t Mie, Japan 1990 T. Ishizu 
S-13t Shizuoka, Japan 1990 K. Ito 
S-18t Shizuoka, Japan 1990 K. Ito 
S-23-1-1" t Shizuoka, Japan 1990 K. Ito 
M-102 IA Mie, Japan 1990 T. Ishizu 
A-113 Aichi, Japan 1990 S. Isomura 
A-188 Aichi, Japan 1990 S. Isomura 
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Table 4.--(continued) 
Strain Genotype Location Year Contributor 
A-193 IA Aichi, Japan 1990 S. Isomura 
A-249 Aichi, Japan 1990 S. Isomura 
A-300 Aichi, Japan 1990 S. Isomura 
A-251 Aichi, Japan 1990 S. Isomura 
* Multiple identical strains collected from different patients involved in a school outbreak or 
common source outbreak of infection, or from family contact. 
t May be distinguished from other strains within the group by sequencing in other genome regions. 
to define various aspects of HAV infection and 
transmission at the level of molecular epidemiology. We 
found several different patterns when we examined the 
geographical distribution of genotypes. One pattern is 
that seen within the U.S.A., for which 15 of the 16 strains 
evaluated were of sub-genotype IA. Moreover, 13 of 
these strains formed a discrete, closely related geographi- 
cal cluster within this genotype (Fig. 1). These data 
suggest the existence of a circulating endemic population 
of HAV. In contrast, strains collected from Western 
Europe (Sweden, Germany, Denmark and Switzerland) 
differ widely in their respective genotypes, suggesting 
that there is little endemic transmission of HAV in this 
geographical region and that most cases are related to 
importation from other regions in which endemic 
transmission occurs. Although the origin of some of these 
strains is known for certain, it can only be surmised in 
most cases (MBB, for example, was recovered in 
Germany from a traveller to Africa) (Table 1). 
Fig. 3 (a) illustrates the genetic relatedness of viruses 
recovered in Sweden, a country with excellent public 
health sanitation services. Among these viruses, the sub- 
genotype IA and IB strains (H148, H153, H152 and 
H201) were generally associated with a history of recent 
travel (Tunisia, West Germany or South America) 
during 1980 to 1982. In contrast, genotype I l iA viruses 
were recovered from cases of HAV predominantly 
associated with parenteral drug abuse within the Malmo 
region during the interval from 1979 to 1985. In only one 
of these sub-genotype IIIA cases was there a history of 
travel (Sri Lanka). Thus, in Sweden, there appears to
have been endemic irculation of a particularly closely 
related group of viruses among parenteral drug users in 
one city, whereas most of the other cases involved quite 
distantly related viruses imported from other geographi- 
cal regions. 
The Japanese strains studied included viruses causing 
sporadic ases as well as outbreaks of hepatitis A (Fig. 
3 b). This relatively small geographical region has a low 
endemic rate of HAV. However, more than one genotype 
of HAV was identified within the same year and even 
within the same location. Remarkably, two unique 
strains of HAV were recovered from different children 
involved in an HAV outbreak which occurred in Kiyama 
Elementary School, Saga Prefecture during 1977. Of 11 
children involved in this outbreak, nine were infected 
with KRM031, a sub-genotype IA strain. However, two 
children were infected with a distantly related sub- 
genotype IIIB virus, KRM016, which was identical in 
sequence to KRM003 (Table 4). KRM031 and KRM003 
differ in sequence at approximately 25~ of base 
positions (Fig 3 b). KRM003 was recovered 2 years later, 
from a sporadic hepatitis A case which occurred in 
Fukuoka Prefecture in 1979. In addition, a very closely 
related virus (A-162) was identified 11 years later in a 
sporadic ase occurring in Aichi Prefecture during 1990. 
A-162 is identical to KRM003 within the genomic region 
analysed in Fig. 1, but these two strains can be 
distinguished by sequencing a larger 360 base segment in 
this region (data not shown). 
Also in Japan, a cluster of seven strains having 
sequences identical to that of strain A-167 was identified 
among cases occurring in four different locations (Table 
4). Two of these viruses, as well as other viruses having 
sequences identical to those of the A-149, M-91 or M-100 
strains, were associated with transmission within fam- 
ilies (data not shown). Thus, the strains of HAV studied 
in Japan probably represent a combination of travel- 
associated and endemic transmission patterns, with local 
spread of otherwise imported viruses. However, 
TKM002 and TKM005 are the only two strains for 
which a history of travel was known (Fig. 3b). These 
were recovered from patients after travel to Nigeria and 
Iraq, respectively. 
Cell culture isolates 
The growth of HAV in cell culture generally requires a 
long adaptation period and generally does not result in a 
c.p.e. Thus the contamination of cultured cells with 
laboratory-passaged strains is a constant possibility. For 
this reason we included in the analysis described above 
only those sequences derived from cell culture-adapted 
viruses that were unique in comparison to common 
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(a) 
Year  Location Name 
1984 Sweden H-209 
1~14 Sweden H-213 
1985 Sweden H-228 
1884 Sweden H-217 
1978 Sweden H-174 
1N4 Sd Lallka H-229 
1979 :S~/~don H-122 
1979 Sweden H-141 
1979 Sweden H-132 
1980 Sweden H-148 
1981 Turdshl H-153 
1~1 W. Gerrnany H*152 
1982 S. Amedcl H-201 
IliA 
A 
I I I I I 
100 95 90 85 80 
Nucleotide identity (%) 
(b) 
Year  Location Name 
1900 Net'/ A-162 
197g Kyushu KRId003 
1990 Alchl A-177 
1gO0 A]chl A*22g 
1990 Mle M-25 
1981 Iraq TKMO05 
1990 MkD M-91 
1990 Alchl A-149 
1990 Mie M-63 
1990 Alchl A-261 
1990 Aichl A-148 
1990 Alchl A-167 
1990 Mle M-118 
1990 AJCN A-185 
1990 AJchl A-127 
1990 Shlzuoka S-3 
1990 Mie M-100 
1990 Mle M-116 
1990 Mle M-53 
1990 Mie M-74 
1990 Shlzuoke. S-6 
1990 AJchi A-12 
1977 Kyushu KRM031 
1981 NIgeda TKM002 
1986 Mie M-136 
1986 Mie M-138 
1990 Alchl A-4 
1990 Mie M-61 
1990 Shtzuoka $23-1 
1990 NCN A-12g 
1990 Mle M-102 
1990 Alchi A-251 
1 
] 
| 
lOO 
IB 
-i 
IIIB 
IA 
I 
75 
I I I I I 
95  90 85 80 75 
Nucleotide identity (%) 
Fig. 3. Dendrograms depicting the g netic relatedness ofhuman HAV 
strains recovered in Sweden (a) and Japan (b). See legend to Fig. 1. 
laboratory isolates of HAV. This resulted in the 
exclusion of 19 virus strains with sequences in this region 
of the genome identical to those of MBB, HM175 or 
HAS15, and which therefore might be contaminants 
(Table 2). MBB, HM175 and HAS15 are well character- 
ized cell culture-adapted isolates (Baroudy et al., 1985; 
Ovchinnikov et al., 1985; Paul et al., 1987). These strains 
were adapted to cell culture relatively early in the history 
of HAV propagation, and each has been widely 
distributed among laboratories engaged in HAV re- 
search. The cell culture-adapted strains listed in Table 2 
were isolated in a number of independent laboratories, 
suggesting that cross-contamination f cell cultures 
might be a generic problem in the isolation of HAV 
strains from clinical materials. In several instances 
(strains marked by the symbol § in Table 1 and an 
asterisk in Table 2 and Fig. 1), the cell culture 'isolate' is 
strongly suspected to be a contaminant because virus 
with a substantially different sequence has been identi- 
fied in the primary clinical specimen (see Fig. 1) (Jansen 
et al., 1990). Although the other isolates listed in Table 2 
must be considered possible contaminants, it should be 
noted that a number of apparently unrelated virus 
strains, studied after direct isolation from primary 
clinical materials, have been found to have identical 
nucleotide sequences in the VP1/2A genomic region (see 
Table 4). 
Stability of HA V genotypes 
To assess the stability of the VP1/2A sequence of HAV 
within infected individuals over a period of time, we 
studied viruses identified in 10 serial specimens collected 
from four different persons. The nucleotide sequence of 
360 bases was determined for each virus. In one case, a 
virus-positive specimen was collected 41 days after 
initial recovery of the virus, whereas in the other cases 
this interval ranged from 11 to 26 days. No sequence 
differences were identified in any of the viruses isolated 
from each of these patients (data not shown). These data 
are consistent with the fact that viruses isolated from 
different patients involved in several different outbreaks 
of hepatitis A always had a common sequence (Table 4). 
In addition, no change was found in the sequence of the 
VP1/2A region after six passages of the KRM003 strain 
in non-human primates (marmosets) (data not shown). A 
single nucleotide substitution (C to T at base 3002, 
HM175 numbering) was identified in this strain follow- 
ing 72 passages in cell culture. 
Discussion 
Limited genomic sequencing of eDNA amplified by 
PCR from viral RNA present within infected stool, liver 
or serum provides a valuable tool for defining popu- 
lations of wild-type HAV strains without he potentially 
confounding factors of extended cell culture adaptation 
or alternative animal passage. Four genotypes of HAV 
associated with human disease have been identified and 
a framework has been constructed for epidemiological 
tracking of wild-type HAV in both endemic and 
epidemic settings, and for differentiating wild-type 
strains from potential vaccine-derived virus in future 
vaccine trials. 
Overall, the seven HAV genotypes recovered from 
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humans and non-human primates differ from each other 
at approximately 15 to 25% of base positions in the 
VPI/2A region. However, HAV does not appear to 
undergo the rapid accumulation of genetic hanges een 
in many RNA viruses. If one assumes a common 
ancestral root for viruses in the IA sub-genotype, and 
accepts the caveat hat the region of the genome we have 
examined reflects the overall pattern of genetic related- 
ness among different strains, an average of 10 substi- 
tutions/year would be predicted to accumulate within the 
entire genome. This may actually be an overestimate, 
because we chose the VP1/2A region for its relative 
variability compared with the VP3 and 5' non-translated 
regions (Brown et al., 1989). In contrast, poliovirus 
averages one to two substitutions/week based upon 
nucleic acid fingerprinting of serial samples examined 
during an epidemic (Nottay et al., 1981; Kew et al., 
1984). Within sub-genotypes of HAV (IA, IB, IIIA or 
IIIB), there is less than 7.5% nucleotide diversity. 
Moreover, within a geographical cluster such as that seen 
in North America (Fig. 1), there is less than 3 % diversity 
between individual strains, even when strains collected 
over a period of 15 years are examined. These obser- 
vations lead one to speculate that HAV strains have 
maintained their low rate of accumulating mutations 
over a long period of time and may have developed 
specific ecological niches. 
Although the overall sequence diversity evident 
among the HAV strains included in Fig. 1 is reminiscent 
of that found among individual serotypes of other 
picornaviruses (Palmenberg, 1989), there are important 
differences. We found only four genotypes among 89 
non-epidemiologically related individual human strains 
(Fig. 1). In contrast, Rico-Hesse t al. (1987) found 19 
genotypes of human poliovirus type 1 strains, using 
identical criteria for genotypic differentiation in a 
similar region of the genome. Moreover, unlike HAV 
there was no correlation between amino acid changes 
and genotype grouping among the polioviruses. Within 
HAV genotypes, there are only limited amino acid 
differences (one or two substitutions in 56 possible 
residues), whereas between genotypes the number of 
amino acid substitutions varies from approximately 3 
(2/56) to about 18% (10/56). Thus, the amino acid 
sequence in the VP1/2A region correlates closely with 
genotype and even sub-genotype, and possibly even 
selected geographical clusters (Fig. 2). The exceptions to 
this observation were strains JF-136 and KPH, which 
grouped genetically as sub-genotypes IA and IIIB, but 
the predicted amino acid sequences ofwhich sorted with 
sub-genotypes IB and IIIA, respectively. 
There is evidence that viruses from different geno- 
types may have different biological phenotypes, particu- 
larly when one contrasts the viruses recovered from Old 
World monkeys (genotypes IV, V and VI) with the 
human strains. These simian-derived HAV agents are 
virulent for the primate species from which they were 
originally recovered, but they do not appear to replicate 
or cause disease when inoculated into chimpanzees, 
which are generally susceptible to human strains (O. 
Nainan et al., unpublished results). In addition, there is 
no evidence ofhuman disease due to the transmission of 
these viruses to animal handlers. These three simian 
strains also have important amino acid substitutions 
(Nainan et al., 1991; Tsarev et al., 1991) within the 
immunodominant antigenic site of HAV (Ping et aL, 
1988), and thus they may represent serological variants 
of HAV. On the other hand, there is no obvious 
difference in disease xpression between genotype I and 
III viruses. Animal transmission studies in Panamanian 
owl monkeys and chimpanzees suggest that both 
genotypes cause classical signs and symptoms of HAV, 
and that representative m mbers of these genotypes 
confer cross-protection against each other (Brown et al., 
1989; Khanna et al., 1991). Moreover, only very minor 
antigenic differences exist between these genotypes 
(Brown et al., 1989). 
Epidemiological tracking of various trains is another 
potential use of the information derived from these 
studies. For example, viruses (H209, H213 and H228) 
recovered from intravenous drug abusers in Malmo, 
Sweden between March 1984 and January 1985 are 
identical in this region, implying sequence conservation 
over a period of approximately 1 year. However, the 
strains we have studied also include several examples of 
viruses which are not closely related epidemiologically, 
but which nonetheless have identical base sequences in
the VP1/P2A region (Table 4). For example, KRM003 
and A-162 viruses, collected in Kyushu and Aichi, Japan 
during 1989 and 1990, are identical in this region, as are 
MT90 and GA90, which were collected in Montana and 
Georgia, U.S.A. during 1990. Another example is 
provided by LV-BE and GR-1, viruses recovered from 
American soldiers in the U.S.A. and Europe during 1982 
(Jansen et al., 1990). Such data provide at least 
presumptive evidence for epidemiological linkage. 
However, the stability of the HAV genome compli- 
cates an absolute assignment of direct genetic linkage 
based upon the sequence of a single region. For example, 
H152 (West Germany, 1981) and HM175 (Australia, 
1976) viruses also share identical sequences in the 
VP1/2A region. Yet, even though these two viruses have 
identical nucleotide sequences in the VP3 coding region 
as well (altogether forming about 5 ~ of the genome), we 
have found significant differences in the sequence of the 
5' non-translated regions of these viruses. Thus, care 
must be taken in reaching strong conclusions about he 
epidemiological relatedness of strains. Similar caution 
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must be exercised in considering that each of the cell 
culture-adapted strains listed in Table 2 is a contaminant 
(although it is likely that most are). 
The sample population used in this analysis contains a
disproportionate number of strains (>47~o) from the 
U.S.A., Sweden and Japan. These three countries all 
have low endemic rates of hepatitis A compared to many 
less developed parts of the world. Consequently, these 
regions are substantially over-represented in this analy- 
sis. Nevertheless, the wide variety of genotypes found in 
both Sweden and Japan suggests that the strains 
recovered within these countries represent a mixture of 
imported strains as well as a continued low level of 
transmission of endemic strain(s) in certain high risk 
groups, such as drug addicts in Sweden (Widell et al., 
1983) or elementary school children in Saga, Japan. By 
contrast, most of the strains from the U.S.A. are tightly 
clustered genetically, suggesting that they represent 
almost exclusive ndemic transmission of a predominant 
genotype which continues to circulate in that country. 
Samples from regions of the world which have a 
hyperendemic pattern of HAV (Gust, 1984), such as 
India, central and south Africa, and parts of South 
America, are particularly under-represented in the 
sample of viruses tudied, although the strains equenced 
represent the vast majority of HAV strains available for 
study world-wide. The strains examined were recovered 
from symptomatic cases of hepatitis A, but residents of 
hyperendemic regions are generally infected with HAV 
at a very early age and do not develop symptomatic 
infection. This may have influenced the number of 
possible clinical specimens available for analysis. 
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